Advertisement

Topics

Sarah Cannon Blood Cancer Network Company Profile

12:49 EDT 19th July 2018 | BioPortfolio

The Sarah Cannon Blood Cancer Network is one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kingdom. Its network conducts over 850 transplants annually and has treated more than 9,500 patients since the inception of our first program. Through its commitment to the highest level of quality standards, infrastructure, training and research, the Sarah Cannon Blood Cancer Network provides an unparalleled experience for patients seeking treatment. For more information about the Blood Cancer Network and Sarah Cannon’s full suite of oncology services, please visit: sarahcannon.com.


News Articles [4314 Associated News Articles listed on BioPortfolio]

Sarah Cannon Blood Cancer Network Leaders to Present 18 Abstracts at the 2018 BMT Tandem Meetings

Today, Sarah Cannon, the Cancer Institute of HCA Healthcare, announced that 18 abstracts authored by members of the Sarah Cannon Blood Cancer Network have been selected for...

Sidney Kimmel Cancer Center – Jefferson Health & Sarah Cannon Research Institute Announce Cancer Drug Development Collaboration

Collaboration between Early Phase Research Leader, Sarah Cannon Research Institute and the NCI-Designated Sidney Kimmel Cancer Center – Jefferson Health to Enhance Clinical Tria...

Sarah Cannon Appoints New Clinical Research and Drug Development Faculty

Sarah Cannon announced today the appointment of three new research faculty to its drug development programs in Nashville, Tenn. and Denver, Colo. Saurin Chokshi, MD, from Yale Uni...

Sarah Cannon Research Institute – UK Offers TIL Therapy to Patients with Metastatic Melanoma

Patients in Europe Now Have Access to Cutting-Edge Immunotherapy in Phase II Clinical Trial Sarah Cannon Research Institute – UK, Part of HCA Healthcare UK, announced...

OncLive® to Host State of the Science Summit™ to Discuss Updates From the 2018 Annual Oncology Meeting

Expert oncologists from renowned institutions gather to review latest in cancer developments OncLive®, the leading digital provider of resources and information to onc...

Sarah Cannon Appoints Axel Grothey as Cancer Research Leader

Sarah Cannon announced today that Axel Grothey, MD, has been appointed the new Director of Gastrointestinal (GI) Cancer Research. Previously a consultant and professor in the Divi...

Sarah Cannon Development Innovations Collaborates with Pivotal on Immuno-Oncology Trials

New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers Collaboration will enable patients ...

Sarah Cannon to Present Latest Cancer Research Insights at 2018 American Society of Clinical Oncology's Annual Meeting

Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 85 presentations at the American Society of Clinical Oncology’s (...

PubMed Articles [9598 Associated PubMed Articles listed on BioPortfolio]

Developing a Model Cancer Registry: The Sarah Cannon Model.

Optimal occlusion uniformly partitions red blood cells fluxes within a microvascular network.

In animals, gas exchange between blood and tissues occurs in narrow vessels, whose diameter is comparable to that of a red blood cell. Red blood cells must deform to squeeze through these narrow vesse...

A systematic review and network meta-analysis protocol of neoadjuvant treatments for patients with gastric cancer.

National Comprehensive Cancer Network (NCCN) guidelines recommend surgery, chemotherapy, and radiation therapy for gastric cancer patients. Neoadjuvant treatments as the administration of therapeutic ...

Corrigendum: Mueller EL, Sabbatini A, Gebremariam A, et al. Why pediatric patients with cancer visit the emergency department: United States, 2006-2010. Pediatr Blood Cancer. 2015;62:490-495. DOI: 10.1002/pbc.25288.

Development of the functional social network index for adolescent and young adult cancer survivors.

To the authors' knowledge, social network status in adolescent and young adult (AYA) cancer survivors has not been adequately studied to date. The authors developed and validated a functional social n...

Clinical Trials [13550 Associated Clinical Trials listed on BioPortfolio]

SCRI TISSUE TESTING REGISTRY

Sarah Cannon Research Institute (SCRI) is committed to improvement and excellence in clinical research and correlative science. To this end, the SCRI Oncology Research Consortium will coll...

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

In this study, patients with metastatic HER2-negative breast cancer will receive treatment with ixabepilone and sorafenib until disease progression or unacceptable toxicity occurs. The Pha...

Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)

GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variatio...

Family Blood Pressure Program - GenNet Network

To identify new genetic loci regulating blood pressure in hypertensive rats and in case-controls from relevant human populations. The study consists of a four grant network, which in turn...

Assessing Community Cancer Care After Insurance ExpanSionS

This innovative and timely study will measure the impact of Affordable Care Act (ACA) Medicaid expansions on cancer screenings and preventive services. To assess this natural policy experi...

Companies [2682 Associated Companies listed on BioPortfolio]

Sarah Cannon Blood Cancer Network

The Sarah Cannon Blood Cancer Network is one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kin...

The Sarah Cannon Blood Cancer Network

Sarah Cannon brings together physician-led blood cancer programs across the United States and United Kingdom to offer patients convenient access to care including blood and marrow...

Sarah Cannon Research Institute (SCRI)

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the world’s leading clinical res...

Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the largest clinical research program...

The Multiple Myeloma Research Consortium

The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myelo...

More Information about "Sarah Cannon Blood Cancer Network" on BioPortfolio

We have published hundreds of Sarah Cannon Blood Cancer Network news stories on BioPortfolio along with dozens of Sarah Cannon Blood Cancer Network Clinical Trials and PubMed Articles about Sarah Cannon Blood Cancer Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sarah Cannon Blood Cancer Network Companies in our database. You can also find out about relevant Sarah Cannon Blood Cancer Network Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Corporate Database Quicklinks



Searches Linking to this Company Record